Ossium Health is a bioengineering stem-cell research company. With a mission to treat diseases such as leukemia or radiation poisoning, Ossium Health uses its understanding of biology to improve the health and longevity of its patients. Additionally, the company has a specialization in Cryopreservation, bone marrow banking, stem cell transplants, and bone marrow transplants. Ossium Health was founded by Dr. Sebastian Eriksson Giwa, Erik Woods, and Kevin Caldwell in 2016 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/25/2023 | Series C | $50.72MM | $xx.xx | $308.87MM | Alumni Ventures, Asahi Kasei, Cpmg, First Round Capital, Manta Ray Venures, Vivo Capital | |
Price per Share
$xx.xx
Shares Outstanding
133,514,438
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
10.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alumni Ventures, Asahi Kasei, Cpmg, First Round Capital, Manta Ray Venures, Vivo Capital
|
||||||
03/10/2021 | Series B-3 | $174,999.93 | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
862,494
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
03/10/2021 | Series B-3 Prime | $174,999.93 | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
862,494
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
03/10/2021 | Series B-2 | $2.7MM | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
10,892,082
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
03/10/2021 | Series B-2 Prime | $2.7MM | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
10,892,082
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
03/10/2021 | Series B-1 Prime | $3.84MM | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
17,301,077
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
03/10/2021 | Series B-1 | $3.84MM | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
17,301,077
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
03/10/2021 | Series B Prime | $25MM | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
77,519,377
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
03/10/2021 | Series B | $25MM | $xx.xx | $233.96MM | First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital | |
Price per Share
$xx.xx
Shares Outstanding
77,519,377
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, General Catalyst, Manta Ray Ventures, Vivo Capital, Xyz Capital
|
||||||
05/14/2018 | Series A-2 | $388,592.99 | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
3,475,787
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Gaingels
|
||||||
05/14/2018 | Series A-2 Prime | $388,592.99 | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
3,475,787
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Gaingels
|
||||||
05/14/2018 | Series A-1 | $475,276.95 | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
8,744,746
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Gaingels
|
||||||
05/14/2018 | Series A-1 Prime | $475,276.95 | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
8,744,746
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Gaingels
|
||||||
05/14/2018 | Series A-3 Prime | $1.08MM | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
10,965,039
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Gaingels
|
||||||
05/14/2018 | Series A-3 | $1.08MM | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
10,965,039
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Gaingels
|
||||||
05/14/2018 | Series A | $3.42MM | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
15,330,761
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Gaingels
|
||||||
05/14/2018 | Series A Prime | $3.42MM | $xx.xx | $42.95MM | Gaingels | |
Price per Share
$xx.xx
Shares Outstanding
15,330,761
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Gaingels
|